WORK Medical Technology Group LTD (WOK), Monday announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology, has struck a one-year exclusive deal with Shanghai Benke Medical Technology for AI-Automated Blood Cell Morphology.
They will be promoting the new AI-Automated Blood Cell Morphology Analyzer in East China throughout 2026. This agreement spans over Jiangsu, Shanghai, and Zhejiang, with a goal of hitting a minimum annual sales target of RMB 10 million.
WORK Medical believes this partnership will help boost commercialization and enhance its brand visibility in China.
WOK is currently trading at $3.26 up $0.51 or 18.54 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.